IQE (IQE) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
8 Jul, 2026Executive summary
Strategic review underway, prioritizing a full sale of Taiwan operations to achieve a debt-free position and enable reinvestment in growth areas.
CEO transition completed, with Jutta Meier appointed and organizational restructuring, including a 10% headcount reduction, to drive operational efficiency and cost discipline.
Focus on extracting value from assets, reducing costs, and targeting growth in GaN power, Display, and microLED segments.
Expanded customer base and pipeline aligned to diversification strategy, especially in GaN Power and microLED.
Financial highlights
Revenue for the year was £118.0m, up 2% year-over-year; adjusted EBITDA improved to £8.2m from £4.3m.
Adjusted LBIT improved from £20.2m to £18.3m.
Adjusted operating cash flow decreased from £15.7m to £6.1m, mainly due to increased working capital for inventory build.
Net operating cash flow was £1.3m; CapEx for the year was £11.4m.
Cash and cash equivalents at end of Q1 2025 were £20.6m, with an undrawn facility of £4.5m.
Outlook and guidance
Revenue and adjusted EBITDA for FY25 expected within analyst forecast ranges (£115.1m–£123.0m revenue; £7.4m–£10.0m EBITDA), with stronger performance anticipated in H2 due to inventory destocking and seasonality.
Strong customer pipeline, especially in AI infrastructure, aerospace, security, and optical communications, expected to drive growth in H2.
CapEx for 2025 projected to remain in low double-digit millions, mainly for GaN expansion and maintenance.
No direct impact from US tariffs; forecasts assume inclusion of Taiwan revenues.
Latest events from IQE
- FY 2026 revenue growth forecast raised to over 30% on strong H1 demand and robust cash position.IQE
H1 2026 TU21 Jul 2026 - 27% revenue growth and positive adjusted EBITDA, led by Wireless gains and Taiwan IPO plans.IQE
H1 202430 Jun 2026 - £81m fundraising, photonics growth, and strong H2 recovery set up >20% revenue growth for 2026.IQE
H2 202528 May 2026 - Board changes, GenAI-driven strategy, and technology innovation highlighted amid industry recovery.IQE
AGM 20243 Feb 2026 - Revenue and order book strength position the group for growth as strategic review advances.IQE
Trading Update12 Jan 2026 - Revenue fell 31% year-over-year to £45.3m, with deepening losses and a potential full sale.IQE
H1 202520 Oct 2025 - IQE launches a strategic review and seeks £15m financing as 2024 revenue remains flat.IQE
Trading Update13 Jun 2025 - H1 2024 revenue up at least 25% year-on-year, with trading meeting expectations.IQE
Trading Update13 Jun 2025 - FY24 revenue and EBITDA to surpass expectations; strategic review and financing progressing.IQE
Trading Update6 Jun 2025